CEO Michael Tardugno stated the following to open the conference."Your company is in the best position it has been since it transitioned from a development company.""On the fundamentals and from a fincial standpoint, the company is strong.""PFS alone may be sufficient enough for unconditional approval depending upon the strength of the data."He also stated the P-value at 0.05, and his belief that this is very generous and represents the FDA's interest in bringing Thermodox to market."THE DRUG WORKS. IT SIMPLY WORKS.""Present value proposition is as exciting as anything in oncology today.""...and here is why..."LISTEN to the entire conference call HERE:http://www.celsion.com/events.cfmHe only had 30 minutes to present. He tried to squeeze in as much info as possible. Any serious investor owes it to himself to hear the conference call.Cheers!;^)
it freakin' works!flog
<<"THE DRUG WORKS. IT SIMPLY WORKS.">>Did FDA say that or CEO say it?I think he wants to sell you some more stocks.P-value of 0.05 is a joke.DCTH's p-value is 0.0001check it out.
You said you sold (although I doubt you ever bought) so just go away... you have no stake, why waste your time? Flying monkey 101 post on a MB you don't own stock in...b4